Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer.

Cao HM, Wan Z, Wu Y, Wang HY, Guan C.

Medicine (Baltimore). 2019 Jul;98(30):e16534. doi: 10.1097/MD.0000000000016534.

2.

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.

Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell'Oglio P, Bravi CA, Fallara G, Pellegrino F, Nocera L, Karakiewicz PI, Tian Z, Freschi M, Montironi R, Montorsi F, Briganti A.

Eur Urol. 2017 Oct;72(4):632-640. doi: 10.1016/j.eururo.2017.03.049. Epub 2017 Apr 12.

PMID:
28412062
3.

External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.

Urol Int. 2013;90(3):277-82. doi: 10.1159/000343993. Epub 2012 Dec 22.

PMID:
23296120
4.

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17.

PMID:
30342844
5.

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.

Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F.

Eur Urol. 2012 Mar;61(3):480-7. doi: 10.1016/j.eururo.2011.10.044. Epub 2011 Nov 7.

PMID:
22078338
6.

Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.

Briganti A, Chun FK, Salonia A, Gallina A, Farina E, Da Pozzo LF, Rigatti P, Montorsi F, Karakiewicz PI.

BJU Int. 2006 Oct;98(4):788-93. Epub 2006 Jun 26.

7.

First Nomogram Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients Undergoing Radioisotope Guided Sentinel Lymph Node Dissection.

Winter A, Kneib T, Rohde M, Henke RP, Wawroschek F.

Urol Int. 2015;95(4):422-8. doi: 10.1159/000431182. Epub 2015 Jul 3.

8.

Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.

Briganti A, Abdollah F, Nini A, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni NM, Salonia A, Colombo R, Freschi M, Rigatti P, Montorsi F.

Eur Urol. 2012 Jun;61(6):1132-8. doi: 10.1016/j.eururo.2011.11.008. Epub 2011 Nov 12.

PMID:
22099610
9.

Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer.

Porcaro AB, De Luyk N, Corsi P, Sebben M, Tafuri A, Processali T, Mattevi D, Pirozzi M, Cerruto MA, Amigoni N, Rizzetto R, Brunelli MA, Migliorini F, Siracusano S, Artibani W.

Urol Int. 2017;99(4):392-399. doi: 10.1159/000476039. Epub 2017 May 10.

PMID:
28486228
10.

External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.

Hansen J, Rink M, Bianchi M, Kluth LA, Tian Z, Ahyai SA, Shariat SF, Briganti A, Steuber T, Fisch M, Graefen M, Karakiewicz PI, Chun FK.

Prostate. 2013 Jan;73(2):211-8. doi: 10.1002/pros.22559. Epub 2012 Jul 20.

PMID:
22821742
11.

Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.

Godoy G, Chong KT, Cronin A, Vickers A, Laudone V, Touijer K, Guillonneau B, Eastham JA, Scardino PT, Coleman JA.

Eur Urol. 2011 Aug;60(2):195-201. doi: 10.1016/j.eururo.2011.01.016. Epub 2011 Jan 18.

PMID:
21257258
12.

A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.

Oh JJ, Park S, Lee SE, Hong SK, Lee S, Lee HM, Lee JK, Ho JN, Yoon S, Byun SS.

Korean J Urol. 2015 Feb;56(2):109-16. doi: 10.4111/kju.2015.56.2.109. Epub 2015 Feb 2.

13.

Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.

Abdollah F, Schmitges J, Sun M, Thuret R, Djahangirian O, Tian Z, Shariat SF, Briganti A, Perrotte P, Montorsi F, Karakiewicz PI.

Urology. 2011 Dec;78(6):1363-7. doi: 10.1016/j.urology.2011.07.1423.

PMID:
22137704
14.

Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5.

Porpiglia F, Manfredi M, Mele F, Bertolo R, Bollito E, Gned D, De Pascale A, Russo F, Passera R, Fiori C, De Luca S.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):85-91. doi: 10.1038/s41391-017-0026-5. Epub 2018 Feb 22.

15.

Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Hinev AI, Anakievski D, Kolev NH, Hadjiev VI.

Urol Int. 2014;92(3):300-5. doi: 10.1159/000354323. Epub 2014 Jan 25.

PMID:
24480972
16.

Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.

Schmitges J, Karakiewicz PI, Sun M, Abdollah F, Budäus L, Isbarn H, Bianchi M, Trinh QD, Schlomm T, Chun FK, Graefen M, Steuber T.

Eur J Surg Oncol. 2012 Jul;38(7):624-9. doi: 10.1016/j.ejso.2012.04.005. Epub 2012 Apr 22.

PMID:
22531769
17.

Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.

Leyh-Bannurah SR, Budäus L, Zaffuto E, Pompe RS, Bandini M, Briganti A, Montorsi F, Schiffmann J, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI.

Urol Oncol. 2018 Feb;36(2):81.e17-81.e24. doi: 10.1016/j.urolonc.2017.10.022. Epub 2017 Dec 14.

PMID:
29248430
18.

Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.

Abdollah F, Klett DE, Sammon JD, Dalela D, Sood A, Hsu L, Diaz M, Gupta N, Peabody JO, Trinh QD, Menon M.

Can J Urol. 2016 Feb;23(1):8141-50.

PMID:
26892054
19.

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

Walz J, Bladou F, Rousseau B, Laroche J, Salem N, Gravis G, Briganti A, Chun FK, Karakiewicz PI, Fournier G.

Urology. 2012 Mar;79(3):546-51. doi: 10.1016/j.urology.2011.11.036.

PMID:
22386393
20.

Prostate-specific antigen associates with extensive lymph node invasion in high-risk prostate cancer.

Porcaro AB, Corsi P, Inverardi D, Sebben M, Tafuri A, Processali T, Mattevi D, De Marchi D, Pirozzi M, Cerruto MA, Amigoni N, Rizzetto R, Brunelli M, Siracusano S, Artibani W.

Tumori. 2018 Aug;104(4):307-311. doi: 10.1177/0300891618765567. Epub 2018 Apr 6.

PMID:
29714659

Supplemental Content

Support Center